Archive: Dec 2013

Geoff Milsom

A New Paradigm in Vendor Partner Management

Leading companies are moving from traditional vendor compliance to vendor partner management — a competitive differentiator in how companies manage their inbound purchase orders (POs) and transportation to increase sales and customer service. Historically, vendor compliance has revolved around chargebacks — the practice of making deductions from the purchase price when vendors break an agreed-upon […]

Read More
Jon Winsett

Seeking Innovation? Stop IT Overspending

Today’s supply chain is one of the most exciting arenas for business innovation. Mobility, cloud computing, big data, and new production techniques such as 3-D printing are breaking down barriers between retailers, consumers, manufacturers, and suppliers. The technology trends driving supply chain innovation are also driving IT costs through the roof. Eighty-nine percent of IT […]

Read More
Darin J. Cooprider

Packaging Postponement: A Game Changer for F&B Companies

Q: Why is packaging postponement an important consideration for food and beverage (F&B) companies? A: Market demands are constantly in flux as holiday seasonality dictates inventory needs. Also, consumers enjoy an unprecedented variety of food formats. Consider the different product quantities and sizes that one might find in a vending machine, a convenience store, a […]

Read More
Jeffrey R. Brashares

Transforming Liquid Assets into Capital Gains

Q: What is the current state of the bulk liquid transportation market? A: Over the past several years, the only viable option for bulk liquid transport has been specially designed tank trucks. These trucks are expensive to produce and maintain, and their quantity is limited. A single truck can only carry a specific type of […]

Read More
Tim Conroy

Pharmaceutical Supply Chain Tackles Track-and-Trace Challenges

New legislation is in the works to prevent counterfeit medicines from entering the pharmaceutical supply chain. These random mixtures of harmful toxic substances are not only illegal; they are extremely dangerous to patients and damaging to the reputations of legitimate pharmaceutical companies. Increased Internet sales, widespread demand for generic drugs, and drug shortages in many […]

Read More